This study is looking at why some people with glioma (a type of brain tumor) join clinical trials and complete them, while others don't. It's an observational study, meaning researchers will collect information about your experiences rather than testing a new treatment. They want to understand what factors, including your background, might make it easier or harder for you to participate in or finish a trial. The goal is to learn how to improve clinical trials for future glioma patients. You can join if you are 18 or older with a confirmed glioma diagnosis and can follow study requirements. The study aims to see how many patients decide to join a glioma trial (measured at 3 months) and how many stay in a trial until it's done (measured at 12 months).

Study design

This is an observational study that plans to include 500 participants. It is not testing a specific intervention or drug.

What's involved

You would need to be willing and able to comply with scheduled visits, laboratory tests, and other requirements of the study.

Compensation

Not stated in the trial record.

Follow-up

The study will measure how many participants remain in a clinical study until completion, measured at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.